Solutions
About Us
Insights
Careers

Real-world characteristics and outcomes of patients with multiple myeloma treated with belantamab mafodotin: a German claims data study. Luna J, d’Estrube T, Jacobsen A, Lehne M, Wellmann-Pichler B, Mevius A, Dornig S. Ann Hematol. 2025

Cost-effectiveness analysis of 20-valent anti-pneumococcal vaccination in the Spanish pediatric population. García FÁ, Martinón-Torres F, Pineda V, López-Ibáñez de Aldecoa A, Gálvez P, Ta A, Perdrizet J. Expert Rev Pharmacoecon Outcomes Res. 2025

Treatment Effect Estimation With Potential Outcomes for a Single-Arm Trial Compared With Historical Controls: A Case Study of Locally Recurrent Head and Neck Squamous Cell Carcinoma Patients Treated With Adjuvant Nivolumab. Harun N, Sparapani R, Laud PW, Sivaganesan S, Leddon JL, Haque S, Tang AL, Wise-Draper TM. Head Neck. 2025

Effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on maternal gestational weight gain in low-income and middle-income countries: a systematic review and individual participant data meta-analysis of randomised clinical trials. Liu E, Partap U, Shinde S, Wang D, Costa JC, Cliffer IR, Wang M, Nookala SK, Subramoney V, Briggs B, Hamer DH, Akurut H, Argaw A, Ashorn U, Chinkhumba J, Desai M, Divala TH, Elliott AM, Gutman JR, Hien A, Huybregts L, Kajubi R, Kakuru A, Kariuki S, Lachat C, Laufer MK, Luntamo M, Maleta K, Mathanga DP, Ochieng T, Ome-Kaius M, Patson N, Roberfroid D, Rogerson SJ, Toe LC, Unger HW, Webb EL, Fawzi WW. EClinicalMedicine. 2025

Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study. Wheatley-Price P, Navani V, Pabani A, Routy B, Snow S, Denault MH, Kim Y, Syed I, Devost N, Hui D, Qadeer RA, Arora P, Velummailum R, Springford A, McKibbon C, Ho C. Lung Cancer. 2025

Matching-Adjusted Indirect Comparison of Sotorasib Versus Adagrasib in Previously Treated Advanced/Metastatic Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation. Chopra D, Lan Z, Waterhouse DM, Wolf J, Felip E, Moradian H, Karim N, Obiozor C, Stollenwerk B. Advances in Therapy. 2025

Impact of Seton Use on Clinical, Patient-Reported, and Healthcare Resource Utilization Outcomes in Complex Crohn’s Perianal Fistulas: A Systematic Literature Review. White I, Karki C, Geransar P, Leisle L, Junker S, Fleshner P. Inflammatory Bowel Diseases. 2025

Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in Germany. Perdrizet J, Schröder D, Kühne F, Schiffner-Rohe J, Laurenz M, Theilacker C, Ilic A, Ta A, von Eiff C. Journal of Medical Economics. 2025

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study. Batyrbekova N, Hultcrantz M, Ravn Landtblom A, Szulkin R, Dickman PW, Andersson TM, Syriopoulou E. British Journal of Haematology. 2025

Indirect Treatment Comparisons in EUnetHTA Relative Effectiveness Assessments: Learnings and Recommendations for the Implementation of EU Joint Clinical Assessments. van Beekhuizen S, Che M, Monfort L, Hashim M, Azough A, Kubitz N, Griffin A, Price M. Pharmacoecon Open. 2025